79
Participants
Start Date
September 30, 2011
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
TU-100
15g daily, orally as 5g three times daily for 8 consecutive weeks
Matching Placebo
15g as 5g three times daily, orally for 8 consecutive weeks
Long Island Clinical Research Associates, LLP, Great Neck
NY Scientific CORP, Hollis
Metropolitan Gastroenterology Group. PC, Chevy Chase
Endoscopic Microsurgery Associates PA, Towson
Clinical Research of West Florida, Inc, Clearwater
PMG Research of Winston-Salem, LLC, Winston-Salem
PMG Research of Salisbury, Salisbury
Gastroenterology Associates of Central Georgia, Macon
Shafran Gastroenterology Center, Winter Park
Gastroenterology Group of Naples, Naples
Digestive Health Center, Ocean Springs
University of Louisville School of Medicine, Louisville
Ohio Gastroenterology and Liver, Cincinnati
Consultants for Clinical Research, Cincinnati
Clinical Research Institute of Michigan, Chesterfield
Center for Digestive Health, Troy
University of Chicago Hospital Medical Center, Chicago
St. Louis Center for Clinical Research, St Louis
Preferred Research Partners Inc, Little Rock
Rocky Mountain Gastroenterology Associates, Lakewood
Advanced Research Institute, Ogden
TRIMED Clinical Trials, Corona
Digestive Care Associates, LLC, San Carlos
University of California at San Francisco, San Francisco
University of Washington Medical Center, Seattle
Atlanta Gastroenterology Associates, LLC, Atlanta
MedRACS, Quincy
Collaborators (1)
Syneos Health
OTHER
Tsumura USA
INDUSTRY